{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:20:09Z","timestamp":1790875209292,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0253-x","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T09:08:47Z","timestamp":1529485727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Kim","family":"Ohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Moncrieffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Scheufen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"F\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Wixler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Tenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"issue":"33","key":"253_CR1","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.1073\/pnas.1003852107","volume":"107","author":"K Nistala","year":"2010","unstructured":"Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A. 2010;107(33):14751\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"253_CR2","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood. 2013;121(14):2647\u201358.","journal-title":"Blood"},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fimmu.2017.00103","volume":"8","author":"CL Duurland","year":"2017","unstructured":"Duurland CL, Brown CC, O'Shaughnessy RF, Wedderburn LR. CD161(+) Tconv and CD161(+) Treg share a transcriptional and functional phenotype despite limited overlap in TCRbeta repertoire. Front Immunol. 2017;8:103.","journal-title":"Front Immunol"},{"issue":"8","key":"253_CR4","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1084\/jem.20080397","volume":"205","author":"L Cosmi","year":"2008","unstructured":"Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med. 2008;205(8):1903\u201316.","journal-title":"J Exp Med"},{"issue":"8","key":"253_CR5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/art.30332","volume":"63","author":"L Cosmi","year":"2011","unstructured":"Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(8):2504\u201315.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"253_CR6","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.4049\/jimmunol.1003251","volume":"186","author":"I Kryczek","year":"2011","unstructured":"Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol. 2011;186(7):4388\u201395.","journal-title":"J Immunol"},{"issue":"6","key":"253_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2389","volume":"17","author":"M Dominguez-Villar","year":"2011","unstructured":"Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med. 2011;17(6):673\u20135.","journal-title":"Nat Med"},{"issue":"18","key":"253_CR8","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","volume":"113","author":"G Beriou","year":"2009","unstructured":"Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009;113(18):4240\u20139.","journal-title":"Blood"},{"issue":"8","key":"253_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/eji.201243296","volume":"43","author":"B Afzali","year":"2013","unstructured":"Afzali B, Mitchell PJ, Edozie FC, Povoleri GA, Dowson SE, Demandt L, et al. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol. 2013;43(8):2043\u201354.","journal-title":"Eur J Immunol"},{"issue":"37","key":"253_CR10","doi-asserted-by":"publisher","first-page":"32366","DOI":"10.1074\/jbc.M111.245811","volume":"286","author":"T Rauen","year":"2011","unstructured":"Rauen T, Benedyk K, Juang YT, Kerkhoff C, Kyttaris VC, Roth J, et al. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus. J Biol Chem. 2011;286(37):32366\u201372.","journal-title":"J Biol Chem"},{"issue":"4","key":"253_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.molmed.2013.02.001","volume":"19","author":"T Rauen","year":"2013","unstructured":"Rauen T, Hedrich CM, Tenbrock K, Tsokos GC. cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. 2013;19(4):262\u20139.","journal-title":"Trends Mol Med"},{"issue":"6","key":"253_CR12","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.4049\/jimmunol.170.6.2971","volume":"170","author":"K Tenbrock","year":"2003","unstructured":"Tenbrock K, Juang YT, Tolnay M, Tsokos GC. The cyclic adenosine 5\u2032-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol. 2003;170(6):2971\u20136.","journal-title":"J Immunol"},{"issue":"9","key":"253_CR13","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.4049\/jimmunol.175.9.5975","volume":"175","author":"K Tenbrock","year":"2005","unstructured":"Tenbrock K, Kyttaris VC, Ahlmann M, Ehrchen JM, Tolnay M, Melkonyan H, et al. The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain. J Immunol. 2005;175(9):5975\u201380.","journal-title":"J Immunol"},{"issue":"8","key":"253_CR14","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.4049\/jimmunol.169.8.4147","volume":"169","author":"K Tenbrock","year":"2002","unstructured":"Tenbrock K, Juang YT, Gourley MF, Nambiar MP, Tsokos GC. Antisense cyclic adenosine 5\u2032-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol. 2002;169(8):4147\u201352.","journal-title":"J Immunol"},{"issue":"50","key":"253_CR15","doi-asserted-by":"publisher","first-page":"43437","DOI":"10.1074\/jbc.M111.299313","volume":"286","author":"T Rauen","year":"2011","unstructured":"Rauen T, Hedrich CM, Juang YT, Tenbrock K, Tsokos GC. cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J Biol Chem. 2011;286(50):43437\u201346.","journal-title":"J Biol Chem"},{"issue":"2","key":"253_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jmcb\/mjs004","volume":"4","author":"R Lippe","year":"2012","unstructured":"Lippe R, Ohl K, Varga G, Rauen T, Crispin JC, Juang YT, et al. CREMalpha overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity. J Mol Cell Biol. 2012;4(2):121\u20133.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"253_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cei.12629","volume":"181","author":"K Ohl","year":"2015","unstructured":"Ohl K, Wiener A, Schippers A, Wagner N, Tenbrock K. IL-2 treatment reverses effects of CREMalpha-overexpressing T cells in autoimmune-prone mice. Clin Exp Immunol. 2015;181(1):76\u201386.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"253_CR18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4049\/jimmunol.1203147","volume":"191","author":"E Verjans","year":"2013","unstructured":"Verjans E, Ohl K, Yu Y, Lippe R, Schippers A, Wiener A, et al. Overexpression of CREMalpha in T cells aggravates lipopolysaccharide-induced acute lung injury. J Immunol. 2013;191(3):1316\u201323.","journal-title":"J Immunol"},{"issue":"36","key":"253_CR19","doi-asserted-by":"publisher","first-page":"38538","DOI":"10.18632\/oncotarget.6041","volume":"6","author":"E Verjans","year":"2015","unstructured":"Verjans E, Ohl K, Reiss LK, van Wijk F, Toncheva AA, Wiener A, et al. The cAMP response element modulator (CREM) regulates TH2 mediated inflammation. Oncotarget. 2015;6(36):38538\u201351.","journal-title":"Oncotarget"},{"key":"253_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3389\/fimmu.2016.00618","volume":"7","author":"K Ohl","year":"2016","unstructured":"Ohl K, Wiener A, Lippe R, Schippers A, Zorn C, Roth J, et al. CREM alpha enhances IL-21 production in T cells in vivo and in vitro. Front Immunol. 2016;7:618.","journal-title":"Front Immunol"},{"issue":"5","key":"253_CR21","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, et al. CaMK4-dependent activation of AKT\/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124(5):2234\u201345.","journal-title":"J Clin Invest"},{"issue":"11","key":"253_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/ni.1945","volume":"11","author":"AB Stittrich","year":"2010","unstructured":"Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol. 2010;11(11):1057\u201362.","journal-title":"Nat Immunol"},{"issue":"6570","key":"253_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/380162a0","volume":"380","author":"JA Blendy","year":"1996","unstructured":"Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G. Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature. 1996;380(6570):162\u20135.","journal-title":"Nature"},{"issue":"3","key":"253_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008;58(3):875\u201387.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"253_CR25","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","volume":"172","author":"IM de Kleer","year":"2004","unstructured":"de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol. 2004;172(10):6435\u201343.","journal-title":"J Immunol"},{"issue":"4","key":"253_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","volume":"115","author":"YT Juang","year":"2005","unstructured":"Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest. 2005;115(4):996\u20131005.","journal-title":"J Clin Invest"},{"issue":"2","key":"253_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.immuni.2011.12.013","volume":"36","author":"V Santarlasci","year":"2012","unstructured":"Santarlasci V, Maggi L, Capone M, Querci V, Beltrame L, Cavalieri D, et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity. 2012;36(2):201\u201314.","journal-title":"Immunity"},{"issue":"7","key":"253_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/annrheumdis-2011-200814","volume":"71","author":"A Hinks","year":"2012","unstructured":"Hinks A, Cobb J, Sudman M, Eyre S, Martin P, Flynn E, et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis. 2012;71(7):1117\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"253_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.24187","volume":"60","author":"A Hinks","year":"2009","unstructured":"Hinks A, Ke X, Barton A, Eyre S, Bowes J, Worthington J, et al. Association of the IL2RA\/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(1):251\u20137.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"253_CR30","first-page":"561","volume":"12","author":"L Lepore","year":"1994","unstructured":"Lepore L, Pennesi M, Saletta S, Perticarari S, Presani G, Prodan M. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol. 1994;12(5):561\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"253_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cei.12629","volume":"181","author":"K Ohl","year":"2015","unstructured":"Ohl K, Wiener A, Schippers A, Wagner N, Tenbrock K. Interleukin-2 treatment reverses effects of cAMP-responsive element modulator alpha-over-expressing T cells in autoimmune-prone mice. Clin Exp Immunol. 2015;181(1):76\u201386.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"253_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.autrev.2016.09.012","volume":"15","author":"L Maggi","year":"2016","unstructured":"Maggi L, Cosmi L, Simonini G, Annunziato F, Cimaz R. T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies. Autoimmun Rev. 2016;15(12):1141\u20134.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"253_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C von Spee-Mayer","year":"2016","unstructured":"von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2016;75(7):1407\u201315.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:53:11Z","timestamp":1569379991000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0253-x","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of human samples was approved by the local ethics committee (Ethics Committee RWTH Aachen, Faculty of Medicine; EK228\/15). All patients had given informed written consent to participate in the study.Experiments involoving animal were approved by the regional government authorities and animal procedures were performed according to German legislation for animal protection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final version to be published. The manuscript does not contain data from any individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"39"}}